Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rang in Aktien #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Aktienkurs
$71.40
Marktkapitalisierung
$29.93B
Veränderung (1 Tag)
-0.13%
Veränderung (1 Jahr)
-51.06%
Land
US
Handel Zoetis Inc. (ZTS)

Kategorie

Healthcare
P/B-Verhältnis für Zoetis Inc. (ZTS)
P/B-Verhältnis zum September 2026 TTM: 9.77
Laut den neuesten Finanzberichten und dem Aktienkurs von Zoetis Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 9.77. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 18.22.
P/B-Verlauf für Zoetis Inc. von 2009 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 9.77 -36.98%
2024 15.51 -14.83%
2023 18.22 16.77%
2022 15.60 -38.78%
2021 25.48 22.03%
2020 20.88 -10.65%
2019 23.37 23.57%
2018 18.91 -5.16%
2017 19.94 11.74%
2016 17.85 -20.41%
2015 22.42 36.33%
2014 16.45 -5.42%
2013 17.39 351.51%
2012 3.85 -3.37%
2011 3.99 -10.11%
2010 4.43 0.00%
2009 0.00 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 29.9692 206.62%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6479 -21.75%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -78.0908 -898.96%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -13.26%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.5385 -12.64%
US